Mark Berger
2018
In 2018, Mark Berger earned a total compensation of $612.3K as Chief Medical Officer at Actinium Pharmaceuticals.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $137,313 |
| Salary | $400,000 |
| Total | $612,313 |
Berger received $400K in salary, accounting for 65% of the total pay in 2018.
Berger also received $75K in bonus and $137.3K in option awards.
Rankings
In 2018, Mark Berger's compensation ranked 11,206th out of 14,244 executives tracked by ExecPay. In other words, Berger earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,206 out of 14,244 | 21st |
Division Manufacturing | 4,532 out of 5,765 | 21st |
Major group Chemicals And Allied Products | 1,716 out of 2,128 | 19th |
Industry group Drugs | 1,456 out of 1,817 | 20th |
Industry Pharmaceutical Preparations | 1,117 out of 1,391 | 20th |
Source: SEC filing on October 7, 2020.
Berger's colleagues
We found three more compensation records of executives who worked with Mark Berger at Actinium Pharmaceuticals in 2018.